pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
ELI LILLY CO · news · pharmadog
← back to ELI LILLY CO
News mentioning ELI LILLY CO
630
stories
Aug 12, 26
Lilly files six lawsuits in bid to shut down ‘black market’ for retatrutide
biopharma dive
Aug 12, 26
Lilly cracks down on black market for obesity asset retatrutide with six lawsuits
biospace
Aug 12, 26
7 companies hiring in North Carolina now
biospace
Aug 12, 26
STAT+: Pharmalittle: We’re reading about Lilly ‘black market’ lawsuits, pushback over Trump vaccine plan, and more
stat
Aug 12, 26
Replimune finally wins approval, Q2 earnings wrap up, psychedelics stay in spotlight
biospace
Aug 12, 26
With tech backing, AI biotechs force biopharma into ‘fail-fast’ drug development
biospace
Aug 11, 26
Definium hits another phase 3 homerun with psychedelic ‘sea change’ for anxiety
fiercebiotech
Aug 11, 26
Lilly paid $2B upfront for vaccine biotechs; Infinimmune raises $75M
endpoints
Aug 11, 26
Amgen lays groundwork for new R&D center in Hyderabad
fiercebiotech
Aug 11, 26
Chasing Dupixent, a biotech aims to make better antibody drugs for eczema
biopharma dive
Aug 11, 26
After billions in deals, Insilico CEO promises: ‘You haven't seen anything yet’
biospace
Aug 10, 26
BMS picks Texas for new $2.3B manufacturing campus
biospace
Aug 10, 26
Scribe’s Benjamin Oakes on a rare IPO and bringing CRISPR to the masses
biopharma dive
Aug 10, 26
As BMS’ Cobenfy struggles to gain traction, MapLight knocks on the door
biospace
Aug 10, 26
Psychedelics on the cusp of market breakthrough as clinical, policy support grow
biospace
Aug 10, 26
Recon: BMS plans $2.3B Houston manufacturing site; MHRA approves Lilly weight-loss drug for weight loss, type 2 diabetes
raps
Aug 7, 26
STAT+: NIH plans to block international researchers on visas from accessing key funding avenue
stat
Aug 7, 26
Why Big Pharma is chasing the industry’s most-powerful supercomputer
biopharma dive
Aug 7, 26
2026 Q2 Job Market Report: Job postings keep rising as fewer companies cut employees
biospace
Aug 7, 26
STAT+: Pharmalittle: We’re reading about Replimune’s melanoma drug, a Medicare policy change, and more
stat
Aug 7, 26
Is the biotech capital of the world moving?
stat
Aug 7, 26
Latigo IPO raises nearly $350M for pain drug development
biopharma dive
Aug 6, 26
Takeda approval ushers in new wave of sleep drugs
biopharma dive
Aug 6, 26
Context scraps bispecific T-cell engager program to extend cash runway deeper into 2027
fiercebiotech
Aug 5, 26
STAT+: Federal regulators invite industry, researchers, and lobbyists to closed-door meetings on clinical AI
stat
Aug 5, 26
STAT+: Federal regulators invite industry, researchers, and lobbyists to closed-door meetings on clinical AI
stat
Aug 5, 26
Erica Schwartz confirmed as CDC director, filling nearly yearlong vacancy
stat
Aug 5, 26
Lilly confident in slow and steady Foundayo launch, as ex-US sales shine
biospace
Aug 5, 26
STAT+: Once again, child dies in gene-editing trial in China, rekindling debate on transparency and safety
stat
Aug 5, 26
Lilly, FDA retatrutide biologic dispute comes to a head as submission nears
biospace
← prev
page 12 of 21
next →
